Federal contractors / MARYLAND DEPARTMENT OF HEALTH

Federal contract award

75F40120C00107

CONDUCT INSPECTIONS OF RETAILERS THAT SELL AND ADVERTISE ANY REGULATED TOBACCO PRODUCTS TO DETERMINE COMPLIANCE AND SUBMIT INSPECTION RESULTS TO FDA.

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeFDA OFFICE OF ACQ GRANT SVCS
NAICS923120 — Administration of Public Health Programs
PSCH199 — Quality Control Services: Miscellaneous
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeCOST NO FEE
Obligations$1.9M
Current contract value$1.9M
Potential contract value / ceiling$2.3M
Start dateAug 31, 2020
Current end dateSep 29, 2024
Potential end dateNov 13, 2024
Latest award activityFeb 9, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Feb 9, 2026P00011$-2.4MTHE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS, CANCEL NON-FUNDED ITEM 5, THEN CLOSE OUT THE CONTRACT.
Nov 13, 2024P00010$0MARYLAND - THE PURPOSE OF THIS ADMINISTRATIVE MODIFICATION IS TO CHANGE THE POP FOR LINE ITEM 4 TO 05/30/24 TO 09/29/24 TO ALLOW INVOICES TO BE PAID

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Madeline BryantContactmadeline.bryant@fda.hhs.gov
240-706-2411		SourceMar 26, 2020
Jennifer MunContactJennifer.Mun@fda.hhs.gov
240-402-7684		SourceMar 26, 2020
Madeline BryantContactmadeline.bryant@fda.hhs.gov
240-706-2411		SourceMar 12, 2020
Jennifer MunContactJennifer.Mun@fda.hhs.gov
240-402-7684		SourceMar 12, 2020
Madeline BryantContactmadeline.bryant@fda.hhs.gov
240-706-2411		SourceMar 5, 2020
Jennifer MunContactJennifer.Mun@fda.hhs.gov
240-402-7684		SourceMar 5, 2020
Madeline BryantContactmadeline.bryant@fda.hhs.gov
240-706-2411		SourceMar 5, 2020
Jennifer MunContactJennifer.Mun@fda.hhs.gov
240-402-7684		SourceMar 5, 2020
Madeline BryantContactmadeline.bryant@fda.hhs.gov
240-706-2411		SourceMar 5, 2020
Madeline BryantContactMadeline.Bryant@fda.hhs.gov
240-402-7611		SourceDec 12, 2019

Research next steps

  1. Verify whether remaining options may extend performance beyond the current end date.
  2. Check the stated set-aside against the solicitation and current certifications.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.